In theory, I would agree with you, however, the catalyst is that the whole biotech sector has been going up over the past 18 months because of increased public interest in purchasing biotech stocks. In a case like this when a whole sector is on fire, then there is no need for a strong catalyst for an individual stock, you just need to look at the supply and demand of the shares, and the combination of indicators that I pointed out, primarily show that the selling has been drying over the past few days and the demand is picking up. Next week's earnings announcement, unless it is disastrous, even if it is in line with expectations, might be used as the trigger for such move.
Now that MMs have cleared all stops and created a short trap, the stock should start to reverse the trend of the past 2 days and make the next leg up to $18 in the next 2 weeks.
The people who shorted the stock will provide the fuel for the next leg up.
#1 pick for perceptive fund. I just bought in today too. Long term hol... when perceptive sells / if there's another huge spike, I'll sell.
Enjoy the ride people.
EASY, but I'm not going to give a specific date. How about right around the corner?
THIS news is HUGE. People don't realize how important it is to have a pill vs intravenous.
You people don't get it....that is what she said!
Oral (pill) will make the intravenous treatment obsolete in the majority of cases!
It looks like the base has been set for the trend and FOLD will go much higher shortly...maybe the FDA meeting will be the trigger! When is the FDA meeting?
I went thru the entire membership of FOLD's Board of Directors and traced out their connectons There are no other obvious fits except for the two that I mentioned earlier... Bristol Myers and Celenge Corporation.
One other passing note. There is a public company called Affymax (connected thru BD member Ted Love) that has a NOL protection plan that might be of interest to Fold. It attempts to limit stock transfers by 5% or more shareholders. I imagine that Ted Love would have brought this to the Board's attention.